\-\ Texto\\:\\ \ \(0\)\
\-\ vitals\\:\\ afebrile\\,\\ hr\\ 82\\,\\ rr\\ 15\\,\\ bp\\ 142\\/89\\,\\ o2\\ sat\\ 97\\%\\ ra\ \(0\)\
\-\ pe\\:\ \(6\)\
\-\ gen\\:\\ anxious\\-appearing\\ male\\ in\\ mild\\ discomfort\ \(0\)\
\-\ heent\\:\\ eomi\\,\\ no\\ pharyngeal\\ erythema\ \(0\)\
\-\ cardiac\\:\\ rrr\\,\\ no\\ murmurs\\,\\ rubs\\ or\\ gallops\\,\\ normal\\ s1\\/s2\ \(0\)\
\-\ lungs\\:\\ cta\\ bilaterally\ \(0\)\
\-\ abd\\:\\ mild\\ diffuse\\ tenderness\\ to\\ palpation\\,\\ no\\ rebound\\ tenderness\\,\\ bs\\ x\\ 4\ \(0\)\
\-\ ext\\:\\ ttp\\ with\\ palpable\\ swelling\\ lateral\\ left\\ 10th\\ rib\ \(0\)\
\-\ labs\\:\ \(4\)\
\-\ wbc\\ 14\\.5\\ \\(no\\ left\\ shift\\)\ \(0\)\
\-\ bun\\ 35\\,\\ cr\\ 1\\.9\\,\\ \\(\\+\\)\\ microscopic\\ hematuria\ \(0\)\
\-\ ca\\ 8\\.2\ \(0\)\
\-\ rcc\\â\\€\\™s\\ are\\ usually\\ resistant\\ to\\ chemotherapy\\ and\\ radiation\\ with\\ the\\ best\\ likelihood\\ of\\ cure\\ being\\ surgical\\ resection\\ \\(radical\\ vs\\.\\ partial\\ nephrectomy\\)\\.\\ \\ unresectable\\ rcc\\â\\€\\™s\\ have\\ a\\ \\<20\\%\\ 5\\-year\\ survival\\ rate\\.\\ \\ cryoprotective\\ nephrectomy\\ can\\ be\\ utilized\\ in\\ patients\\ in\\ good\\ status\\ with\\ metastatic\\ primary\\ disease\\.\\ \\ other\\ options\\ include\\ arterial\\ tumor\\ embolization\\,\\ hormone\\ therapy\\ and\\ immunotherapy\\.\\ \\ infrequent\\ but\\ reproducible\\ responses\\ have\\ been\\ noted\\ to\\ a\\-interferon\\ and\\ il\\-2\\ therapy\\ in\\ combination\\ with\\ anti\\-angiogenic\\ chemotherapy\\.\\ \\ five\\-year\\ survival\\ is\\ 90\\-100\\%\\ when\\ tumor\\ is\\ confined\\ to\\ the\\ renal\\ capsule\\ but\\ drops\\ to\\ \\<50\\%\\ when\\ the\\ capsule\\ has\\ been\\ invaded\\.\\ \\ metastatic\\ disease\\ to\\ local\\ or\\ distant\\ lymph\\ nodes\\ results\\ in\\ a\\ 10\\-15\\%\\ 5\\-year\\ survival\\.\ \(0\)\
\-\ \\â\\€\\¢\\ pa\\ and\\ lateral\\ chest\\ radiograph\ \(0\)\
\-\ 1\\)\\ lytic\\ bone\\ lesions\\ of\\ the\\ right\\ posterior\\ 3rd\\ rib\\ and\\ left\\ lateral\\ 10th\\ rib\\ with\\ associated\\ soft\\ tissue\\ masses\\ likely\\ to\\ represent\\ metastatic\\ disease\\.\ \(0\)\
\-\ \\â\\€\\¢\\ bone\\ scan\\:\ \(0\)\
\-\ 1\\)\\ areas\\ of\\ photopenia\\ with\\ subtle\\ regions\\ of\\ increased\\ activity\\ at\\ left\\ antero\\-lateral\\ 10th\\ rib\\ and\\ right\\ posterior\\ 3rd\\ rib\\.\\ \\ cannot\\ exclude\\ metastatic\\ disease\\.\ \(0\)\
\-\ 2\\)poorly\\ visualized\\ right\\ renal\\ upper\\ pole\\ \\-\\ unable\\ to\\ exclude\\ pathologic\\ abnormality\\.\\ \\ \ \(0\)\
\-\ \\ \ \(1082074\)\
\-\ \\â\\€\\¢\\ ct\\ thorax\\/abdomen\\ with\\ iv\\ and\\ po\\ contrast\\:\ \(0\)\
\-\ 1\\)\\ heterogeneous\\ mass\\ involving\\ the\\ superior\\ pole\\ of\\ the\\ right\\ kidney\\ consistent\\ with\\ area\\ of\\ photopenia\\ on\\ bone\\ scan\\ concerning\\ for\\ rcc\\.\\ \\ accompanying\\ right\\ adrenal\\ mass\\ and\\ expansile\\ destructive\\ lytic\\ lesions\\ left\\ 10th\\ rib\\ and\\ right\\ 3rd\\ rib\\ concerning\\ for\\ metastasis\\.\\ \\ \\ multiple\\ low\\ attenuating\\ cystic\\ structures\\ noted\\ throughout\\ the\\ bilateral\\ kidneys\\ consistent\\ with\\ renal\\ cysts\\.\ \(0\)\
\-\ renal\\ cell\\ carcinoma\\ with\\ lytic\\ metastasis\ \(0\)\
\-\ renal\\ cell\\ carcinoma\\ \ \(22\)\
\-\ angiomyolipoma\ \(35\)\
\-\ collecting\\ duct\\ carcinoma\ \(1\)\
\-\ hemorrhagic\\ cyst\ \(15\)\
\-\ infected\\ cyst\ \(1\)\
\-\ lymphoma\ \(373\)\
\-\ mets\ \(38\)\
\-\ oncocytoma\ \(13\)\
\-\ abscess\ \(594\)\
\-\ transitional\\ cell\\ carcinoma\ \(13\)\
\-\ differential\\ dx\\ cold\\ lesion\\ on\\ bone\\ scintigraphy\\:\ \(0\)\
\-\ metastasis\\-\\ renal\\,\\ thyroid\\,\\ breast\\,\\ lung\ \(0\)\
\-\ myeloma\ \(71\)\
\-\ infarct\\ \\(early\\)\ \(0\)\
\-\ radiation\\ tx\ \(2\)\
\-\ bone\\ cyst\ \(88\)\
\-\ prostheses\\ or\\ attenuation\\ artifacts\ \(0\)\
\-\ children\\-\\ consider\\ infection\\ and\\ neuroblastoma\ \(0\)\
\-\ 70\\ y\\.o\\.\\ hispanic\\ male\\ presents\\ to\\ ed\\ with\\ luq\\ pain\\,\\ fever\\,\\ chills\\ and\\ diaphoresis\\ s\\/p\\ return\\ from\\ vacation\\ to\\ mexico\\.\\ hx\\ of\\ documented\\ lytic\\ lesion\\ left\\ 10th\\ rib\\ and\\ right\\ 3rd\\ rib\\ on\\ ct\\ scan\\ 1\\ yr\\ prior\\.\\ \\ notes\\ weight\\ loss\\ x\\ 1\\ year\\.\\ denies\\ night\\ sweats\\.\ \(0\)\
\-\ denies\\ nausea\\ or\\ vomiting\\.\\ no\\ hematemesis\\ or\\ hematochezia\\/melena\\.\ \(0\)\
\-\ renal\\ cell\\ carcinoma\\ is\\ the\\ most\\ common\\ primary\\ renal\\ tumor\\ in\\ adults\\ \\(85\\%\\)\\ and\\ accounts\\ for\\ 2\\%\\ of\\ all\\ malignancies\\.\\ \\ risk\\ factors\\ include\\ increased\\ age\\ \\(50\\-70\\)\\,\\ smoking\\ history\\ \\(dose\\-dependent\\)\\,\\ male\\,\\ cadmium\\/benzene\\/asbestos\\ exposure\\,\\ chronic\\ dialysis\\,\\ excessive\\ phenacetin\\ ingestion\\ and\\ hereditary\\ genetic\\ predispositions\\.\\ \\ bilateral\\ rcc\\â\\€\\™s\\ are\\ more\\ common\\ in\\ von\\ hippel\\-lindau\\,\\ tuberous\\ sclerosis\\ and\\ familial\\ rcc\\,\\ however\\ bilateral\\ disease\\ occurs\\ in\\ only\\ 2\\%\\ of\\ patients\\.\\ unilateral\\ disease\\ is\\ multi\\-centric\\ in\\ 25\\%\\ of\\ all\\ diagnosed\\.\\ \\ \ \(0\)\
\-\ malignant\\ cells\\ arise\\ from\\ the\\ proximal\\ tubular\\ epithelium\\ and\\ are\\ located\\ in\\ the\\ renal\\ cortex\\ with\\ multiple\\ pathologic\\ subtypes\\ to\\ include\\ clear\\ cell\\ \\(75\\%\\)\\,\\ papillary\\,\\ granular\\ and\\ collecting\\ duct\\ carcinoma\\.\\ \\ imaging\\ often\\ reveals\\ the\\ heterogeneity\\ of\\ these\\ tumors\\ ranging\\ from\\ completely\\ cystic\\ to\\ solid\\.\\ staging\\ can\\ be\\ accomplished\\ with\\ either\\ the\\ tnm\\ \\(tumor\\,\\ node\\,\\ metastasis\\)\\ system\\ or\\ the\\ robson\\ criteria\\:\ \(0\)\
\-\ tnm\\ guidelines\\ \\-\\ considered\\ to\\ be\\ more\\ precise\\ due\\ to\\ clear\\ definition\\ of\\ anatomic\\ extent\\ of\\ the\\ tumor\ \(0\)\
\-\ \\â\\€\\¢\\ stage\\ 1\\ rccs\\ are\\ 7\\ cm\\ or\\ smaller\\ and\\ confined\\ to\\ the\\ kidney\\.\\ \ \(0\)\
\-\ \\â\\€\\¢\\ stage\\ 2\\ rccs\\ are\\ larger\\ than\\ 7\\ cm\\ but\\ still\\ organ\\ confined\\.\\ \ \(0\)\
\-\ \\â\\€\\¢\\ stage\\ 3\\ is\\ subdivided\\ into\\ three\\ groups\\:\ \(0\)\
\-\ \\ \\ \\-\\ t3a\\ involves\\ perinephric\\ fat\ \(0\)\
\-\ \\ \\ \\-\\ t3b\\ extension\\ into\\ the\\ renal\\ vein\\ or\\ vena\\ cava\\,\\ involve\\ the\\ ipsilateral\\ adrenal\\ gland\\,or\\ have\\ spread\\ to\\ one\\ local\\ lymph\\ node\\.\\ \ \(0\)\
\-\ \\ \\ \\-\\ t3c\\ tumor\\ involves\\ infradiaphragmatic\\ ivc\ \(0\)\
\-\ \\â\\€\\¢\\ stage\\ 4\\ tumors\\ extend\\ beyond\\ the\\ gerota\\ fascia\\,\\ to\\ more\\ than\\ one\\ local\\ node\\ or\\ have\\ distant\\ metastases\ \(0\)\
\-\ robson\\ criteria\ \(0\)\
\-\ i\\ \\ tumor\\ confined\\ within\\ the\\ renal\\ capsule\\.\\ \ \(0\)\
\-\ ii\\ invasion\\ into\\ perinephric\\ fat\\ but\\ contained\\ within\\ the\\ gerota\\ fascia\\ \\(involvement\\ of\\ ipsilateral\\ adrenal\\ gland\\)\\.\\ \ \(0\)\
\-\ iiia\\ invasion\\ of\\ renal\\ vein\\ or\\ ivc\\ \\(w\\ or\\ w\\/o\\ venous\\ thrombus\\)\ \(0\)\
\-\ iiib\\ regional\\ lymph\\ node\\ involvement\ \(0\)\
\-\ iiic\\ invasion\\ of\\ both\\ renal\\ vein\\/ivc\\ and\\ regional\\ lymph\\ nodes\ \(0\)\
\-\ iva\\ direct\\ invasion\\ of\\ adjacent\\ organs\\ \ \(0\)\
\-\ ivb\\ distant\\ metastases\ \(0\)\
\-\ renal\\ cell\\ carcinoma\\ is\\ diagnosed\\ incidentally\\ in\\ 50\\%\\ of\\ cases\\ and\\ often\\ presents\\ with\\ flank\\ pain\\,\\ mass\\,\\ hematuria\\ \\(gross\\ vs\\.\\ microscopic\\)\\ or\\ noted\\ on\\ imaging\\.\\ \\ secondary\\ findings\\ include\\ weight\\ loss\\,\\ fever\\,\\ hypertension\\,\\ hypercalcemia\\ and\\ a\\ variety\\ of\\ paraneoplastic\\ syndromes\\.\\ \\ ct\\ is\\ the\\ most\\ valuable\\ imaging\\ modality\\ to\\ confirm\\ size\\ and\\ involvement\\ of\\ local\\ structures\\ with\\ 91\\%\\ accuracy\\ in\\ staging\\.\\ \\ \ \(0\)\
\-\ bosniak\\ guidelines\\ for\\ evaluation\\ of\\ cystic\\ renal\\ masses\\ on\\ ct\ \(0\)\
\-\ i\\)\\ simple\\,\\ benign\\ cysts\\ with\\ homogeneity\\,\\ water\\ density\\ and\\ a\\ sharp\\ interface\\ without\\ wall\\ thickness\\,\\ calcification\\ or\\ enhancement\ \(0\)\
\-\ ii\\)\\ cystic\\ with\\ one\\/two\\ thin\\ septations\\,\\ thin\\/fine\\ calcifications\\ and\\ hyperdense\\ benign\\ lesions\ \(0\)\
\-\ iif\\)\\ need\\ f\\/u\\ secondary\\ to\\ minimally\\ complicated\\ cysts\ \(0\)\
\-\ iii\\)\\ indeterminate\\ cystic\\ masses\\ requiring\\ surgical\\ evaluation\\ due\\ to\\ wall\\ thickness\\,\\ nodularity\\,\\ thick\\/\\ irregular\\ peripheral\\ calcifications\\ with\\ multilocular\\ enhancing\\ septa\ \(0\)\
\-\ iv\\)\\ non\\-uniform\\,\\ thick\\,\\ enhancing\\ wall\\ with\\ large\\ nodules\\ and\\ solid\\ components\\.\ \(0\)\
\-\ often\\ appears\\ as\\ a\\ heterogeneous\\ exophytic\\ mass\\ with\\ distortion\\ of\\ the\\ renal\\ contour\\ secondary\\ to\\ hemorrhage\\ and\\ necrosis\\.\\ \\ metastatic\\ disease\\ involves\\ direct\\ local\\ invasion\\ of\\ the\\ adrenal\\ glands\\,\\ liver\\,\\ spleen\\,\\ colon\\ and\\ pancreas\\ with\\ local\\ lymphadenopathy\\.\\ \\ rcc\\â\\€\\™s\\ can\\ extend\\ into\\ the\\ renal\\ vein\\ and\\ ultimately\\ the\\ ivc\\ resulting\\ in\\ thrombosis\\.\\ \\ the\\ lungs\\ as\\ the\\ \\#1\\ site\\ for\\ distant\\ metastasis\\.\\ skeletal\\ lesions\\ are\\ purely\\ lytic\\ in\\ nature\\,\\ well\\-defined\\ as\\ a\\ focal\\ photopenic\\ defect\\ on\\ technetium\\ 99m\\ mdp\\ bone\\ scan\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ 1\\)\\ older\\,\\ robert\\ and\\ resnick\\,\\ martin\\.\\ diagnosis\\ of\\ genitourinary\\ disease\\.\\ thieme\\:\\ 1997\\.\ \(0\)\
\-\ 2\\)\\ pollack\\,\\ m\\.\\ howard\\ et\\ al\\.\\ clinical\\ urography\\,\\ 2nd\\ ed\\.\\ vol\\ 2\\ w\\.b\\.\\ saunders\\ company\\:\\ philadelphia\\,\\ 2000\\ \ \(0\)\
\-\ 3\\)\\ weissleder\\,\\ ralph\\ et\\ al\\.\\ primer\\ of\\ diagnostic\\ imaging\\,\\ 2nd\\ ed\\.\\ mosby\\:\\ philadelphia\\,\\ 1997\\ brant\\ we\\,\\ helms\\ ca\\.\\ fundamentals\\ of\\ diagnostic\\ radiology\\.\\ 2nd\\ ed\\.\\ philadelphia\\:\\ lippincott\\ williams\\ and\\ wilkins\\.\\ 1999\\.\ \(0\)\
\-\ 4\\)\\ rugo\\ hope\\ s\\,\\ \\"oncology\\"\\ \\(chapter\\)\\.\\ mcphee\\ sj\\,\\ papadakis\\ ma\\,\\ tierney\\ lm\\,\\ jr\\.\\:\\ current\\ medical\\ diagnosis\\ \\&\\ treatment\\ 2008\ \(0\)\
\-\ 5\\)\\ sheth\\,\\ sheila\\ et\\ al\\.\\ \\â\\€\\œcurrent\\ concepts\\ in\\ the\\ diagnosis\\ and\\ management\\ of\\ renal\\ cell\\ carcinoma\\:\\ role\\ of\\ multidector\\ ct\\ and\\ three\\-dimensional\\ ct\\.\\â\\€\\\\ radiographics\\ 2001\\;\\ 21\\:\\ s237\\-\\ s254\\.\\ \ \(0\)\
\-\ 6\\)\\ cotran\\ rs\\,\\ kumar\\ v\\,\\ robbins\\ sl\\.\\ robbins\\ pathologic\\ basis\\ of\\ disease\\.\\ 4th\\ ed\\.\\ philadelphia\\,\\ pa\\:\\ wb\\ saunders\\ co\\;\\ 1989\\:777\\.\ \(0\)\
\-\ 7\\)\\ higgins\\ cb\\.\\ essentials\\ of\\ cardiac\\ radiology\\ and\\ imaging\\.\\ philadelphia\\,\\ pa\\:\\ jb\\ lippincott\\ co\\;\\ 1992\\:283\\-331\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ renal\\:\\ 0\\.27517185253312954\ \(0\)\
\-\ rib\\:\\ 0\\.20181216419759956\ \(0\)\
\-\ rcc\\:\\ 0\\.17363808633252037\ \(0\)\
\-\ and\\:\\ 0\\.1674004219741986\ \(0\)\
\-\ 10th\\:\\ 0\\.1560187152003118\ \(0\)\
\-\ of\\:\\ 0\\.14412362835643747\ \(0\)\
\-\ the\\:\\ 0\\.13715534388838335\ \(0\)\
\-\ to\\:\\ 0\\.12888097723676917\ \(0\)\
\-\ local\\:\\ 0\\.12679237247815328\ \(0\)\
\-\ philadelphia\\:\\ 0\\.12421337151871274\ \(0\)\
\-\ or\\:\\ 0\\.11956199829454768\ \(0\)\
\-\ carcinoma\\:\\ 0\\.1174725806538318\ \(0\)\
\-\ invasion\\:\\ 0\\.10948802745291994\ \(0\)\
\-\ confined\\:\\ 0\\.10504240315315765\ \(0\)\
\-\ lytic\\:\\ 0\\.1033931951289043\ \(0\)\
\-\ distant\\:\\ 0\\.10269137076554104\ \(0\)\
\-\ with\\:\\ 0\\.10094681953302637\ \(0\)\
\-\ cell\\:\\ 0\\.09830191483513993\ \(0\)\
\-\ ed\\:\\ 0\\.09819369985531219\ \(0\)\
\-\ ivc\\:\\ 0\\.09534921502686948\ \(0\)\
\-\ disease\\:\\ 0\\.09274299563528238\ \(0\)\
\-\ in\\:\\ 0\\.09160473238123677\ \(0\)\
\-\ adrenal\\:\\ 0\\.09094353833196785\ \(0\)\
\-\ metastasis\\:\\ 0\\.08996283408877286\ \(0\)\
\-\ tumor\\:\\ 0\\.08988367784003705\ \(0\)\
\-\ 3rd\\:\\ 0\\.08969429519893314\ \(0\)\
\-\ node\\:\\ 0\\.0844012060100562\ \(0\)\
\-\ bone\\:\\ 0\\.08036803505853066\ \(0\)\
\-\ rccs\\:\\ 0\\.07851823219919216\ \(0\)\
\-\ stage\\:\\ 0\\.07819817706722723\ \(0\)\
\-\ lymph\\:\\ 0\\.07635802188757175\ \(0\)\
\-\ cystic\\:\\ 0\\.07392498855988694\ \(0\)\
\-\ tnm\\:\\ 0\\.07255226080170522\ \(0\)\
\-\ robson\\:\\ 0\\.07255226080170522\ \(0\)\
\-\ capsule\\:\\ 0\\.07206138211003671\ \(0\)\
\-\ survival\\:\\ 0\\.0718756146457245\ \(0\)\
\-\ vein\\:\\ 0\\.07038556413175276\ \(0\)\
\-\ robbins\\:\\ 0\\.06906239125380037\ \(0\)\
\-\ 2nd\\:\\ 0\\.06740047742631523\ \(0\)\
\-\ metastatic\\:\\ 0\\.06731935641501187\ \(0\)\
\-\ photopenia\\:\\ 0\\.06658628940421829\ \(0\)\
\-\ gerota\\:\\ 0\\.06466567559807283\ \(0\)\
\-\ imaging\\:\\ 0\\.06450652128540366\ \(0\)\
\-\ involves\\:\\ 0\\.06408360572140585\ \(0\)\
\-\ pathologic\\:\\ 0\\.06034426149313997\ \(0\)\
\-\ guidelines\\:\\ 0\\.05960655030840859\ \(0\)\
\-\ al\\:\\ 0\\.05851689067745868\ \(0\)\
\-\ include\\:\\ 0\\.058425608060135435\ \(0\)\
\-\ scan\\:\\ 0\\.05825847903181514\ \(0\)\
\-\ et\\:\\ 0\\.05769185322763685\ \(0\)\
\-\ fascia\\:\\ 0\\.05713044845882651\ \(0\)\
\-\ co\\:\\ 0\\.05713044845882651\ \(0\)\
\-\ right\\:\\ 0\\.056972949664371435\ \(0\)\
\-\ pa\\:\\ 0\\.056517351530214976\ \(0\)\
\-\ lesions\\:\\ 0\\.05639496288935111\ \(0\)\
\-\ ct\\:\\ 0\\.0560760955409056\ \(0\)\
\-\ are\\:\\ 0\\.05589126130823032\ \(0\)\
\-\ cysts\\:\\ 0\\.055807498304580296\ \(0\)\
\-\ microscopic\\:\\ 0\\.05520983465268105\ \(0\)\
\-\ perinephric\\:\\ 0\\.0549276101113757\ \(0\)\
\-\ regional\\:\\ 0\\.054654346609244425\ \(0\)\
\-\ saunders\\:\\ 0\\.05364057891092167\ \(0\)\
\-\ lippincott\\:\\ 0\\.05364057891092167\ \(0\)\
\-\ involvement\\:\\ 0\\.053303950232162556\ \(0\)\
\-\ into\\:\\ 0\\.052199197820066504\ \(0\)\
\-\ 50\\:\\ 0\\.05143311003453549\ \(0\)\
\-\ ipsilateral\\:\\ 0\\.0508131189969535\ \(0\)\
\-\ left\\:\\ 0\\.050245094477399714\ \(0\)\
\-\ nephrectomy\\:\\ 0\\.05015070936301682\ \(0\)\
\-\ staging\\:\\ 0\\.05015070936301682\ \(0\)\
\-\ masses\\:\\ 0\\.050137365620487796\ \(0\)\
\-\ have\\:\\ 0\\.049054189203163005\ \(0\)\
\-\ lateral\\:\\ 0\\.048732419933847256\ \(0\)\
\-\ criteria\\:\\ 0\\.04868837521175749\ \(0\)\
\-\ but\\:\\ 0\\.04855797744456992\ \(0\)\
\-\ 1997\\:\\ 0\\.048554929479005395\ \(0\)\
\-\ often\\:\\ 0\\.04805456587936688\ \(0\)\
\-\ exclude\\:\\ 0\\.047438782423307804\ \(0\)\
\-\ concerning\\:\\ 0\\.04709673434073723\ \(0\)\
\-\ is\\:\\ 0\\.047060278074884304\ \(0\)\
\-\ thick\\:\\ 0\\.046660839815111974\ \(0\)\
\-\ collecting\\:\\ 0\\.04604578698482111\ \(0\)\
\-\ thickness\\:\\ 0\\.045564819557109046\ \(0\)\
\-\ extend\\:\\ 0\\.04528863295175754\ \(0\)\
\-\ wall\\:\\ 0\\.04480023091331825\ \(0\)\
\-\ on\\:\\ 0\\.04448522648034437\ \(0\)\
\-\ secondary\\:\\ 0\\.04365234600329073\ \(0\)\
\-\ hematuria\\:\\ 0\\.043422552025074106\ \(0\)\
\-\ direct\\:\\ 0\\.04327789185770718\ \(0\)\
\-\ current\\:\\ 0\\.04299566731640184\ \(0\)\
\-\ pole\\:\\ 0\\.04278991064934142\ \(0\)\
\-\ cyst\\:\\ 0\\.0424841529383051\ \(0\)\
\-\ duct\\:\\ 0\\.04226412415938442\ \(0\)\
\-\ one\\:\\ 0\\.04216627957165027\ \(0\)\
\-\ ca\\:\\ 0\\.04188984443737874\ \(0\)\
\-\ nodes\\:\\ 0\\.0417086361159478\ \(0\)\
\-\ 70\\:\\ 0\\.04053693596181595\ \(0\)\
\-\ more\\:\\ 0\\.04043999847537049\ \(0\)\
\-\ no\\:\\ 0\\.03991519676077011\ \(0\)\
\-\ gland\\:\\ 0\\.039884191772296705\ \(0\)\
\-\ metastases\\:\\ 0\\.03969291551504797\ \(0\)\
\-\ denies\\:\\ 0\\.03959884815962211\ \(0\)\
\-\ bilateral\\:\\ 0\\.03958053556454153\ \(0\)\
\-\ radiology\\:\\ 0\\.03932266155427062\ \(0\)\
\-\ cryoprotective\\:\\ 0\\.03925911609959608\ \(0\)\
\-\ phenacetin\\:\\ 0\\.03925911609959608\ \(0\)\
\-\ predispositions\\:\\ 0\\.03925911609959608\ \(0\)\
\-\ thieme\\:\\ 0\\.03925911609959608\ \(0\)\
\-\ pollack\\:\\ 0\\.03925911609959608\ \(0\)\
\-\ ralph\\:\\ 0\\.03925911609959608\ \(0\)\
\-\ rugo\\:\\ 0\\.03925911609959608\ \(0\)\
\-\ sheth\\:\\ 0\\.03925911609959608\ \(0\)\
\-\ sheila\\:\\ 0\\.03925911609959608\ \(0\)\
\-\ multidector\\:\\ 0\\.03925911609959608\ \(0\)\
\-\ s254\\:\\ 0\\.03925911609959608\ \(0\)\
\-\ noted\\:\\ 0\\.03904745275676607\ \(0\)\
\-\ ii\\:\\ 0\\.038710733457123246\ \(0\)\
\-\ can\\:\\ 0\\.03864753444573994\ \(0\)\
\-\ thin\\:\\ 0\\.038218766568042954\ \(0\)\
\-\ diagnosis\\:\\ 0\\.03817800575615741\ \(0\)\
\-\ solid\\:\\ 0\\.037640893395345446\ \(0\)\
\-\ subdivided\\:\\ 0\\.03751418132564365\ \(0\)\
\-\ t3a\\:\\ 0\\.03751418132564365\ \(0\)\
\-\ t3b\\:\\ 0\\.03751418132564365\ \(0\)\
\-\ t3c\\:\\ 0\\.03751418132564365\ \(0\)\
\-\ tierney\\:\\ 0\\.03751418132564365\ \(0\)\
\-\ mass\\:\\ 0\\.03750817493594785\ \(0\)\
\-\ vs\\:\\ 0\\.03745658062758717\ \(0\)\
\-\ diagnostic\\:\\ 0\\.03742018701163394\ \(0\)\
\-\ for\\:\\ 0\\.03720299238784949\ \(0\)\
\-\ structures\\:\\ 0\\.036891979743331846\ \(0\)\
\-\ cardiac\\:\\ 0\\.036459037396555365\ \(0\)\
\-\ immunotherapy\\:\\ 0\\.03627613040085261\ \(0\)\
\-\ vacation\\:\\ 0\\.03627613040085261\ \(0\)\
\-\ mexico\\:\\ 0\\.03627613040085261\ \(0\)\
\-\ iiic\\:\\ 0\\.03627613040085261\ \(0\)\
\-\ bosniak\\:\\ 0\\.03627613040085261\ \(0\)\
\-\ iif\\:\\ 0\\.03627613040085261\ \(0\)\
\-\ howard\\:\\ 0\\.03627613040085261\ \(0\)\
\-\ mcphee\\:\\ 0\\.03627613040085261\ \(0\)\
\-\ papadakis\\:\\ 0\\.03627613040085261\ \(0\)\
\-\ cotran\\:\\ 0\\.03627613040085261\ \(0\)\
\-\ higgins\\:\\ 0\\.03627613040085261\ \(0\)\
\-\ cb\\:\\ 0\\.03627613040085261\ \(0\)\
\-\ lungs\\:\\ 0\\.036234631607541166\ \(0\)\
\-\ tumors\\:\\ 0\\.03610897861171727\ \(0\)\
\-\ calcifications\\:\\ 0\\.035832792006365764\ \(0\)\
\-\ clear\\:\\ 0\\.03559451859383597\ \(0\)\
\-\ diagnosed\\:\\ 0\\.03556519291862073\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.03553596682144171\ \(0\)\
\-\ infradiaphragmatic\\:\\ 0\\.03531582349777988\ \(0\)\
\-\ martin\\:\\ 0\\.03531582349777988\ \(0\)\
\-\ kumar\\:\\ 0\\.03531582349777988\ \(0\)\
\-\ iv\\:\\ 0\\.035081362032934084\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.03486275784186086\ \(0\)\
\-\ iva\\:\\ 0\\.034531195626900185\ \(0\)\
\-\ ivb\\:\\ 0\\.034531195626900185\ \(0\)\
\-\ purely\\:\\ 0\\.034531195626900185\ \(0\)\
\-\ weissleder\\:\\ 0\\.034531195626900185\ \(0\)\
\-\ rs\\:\\ 0\\.034531195626900185\ \(0\)\
\-\ kidney\\:\\ 0\\.034493071930011186\ \(0\)\
\-\ weight\\:\\ 0\\.03423840609390962\ \(0\)\
\-\ unresectable\\:\\ 0\\.033867802214544634\ \(0\)\
\-\ iiia\\:\\ 0\\.033867802214544634\ \(0\)\
\-\ homogeneity\\:\\ 0\\.033867802214544634\ \(0\)\
\-\ primer\\:\\ 0\\.033867802214544634\ \(0\)\
\-\ lm\\:\\ 0\\.033867802214544634\ \(0\)\
\-\ benign\\:\\ 0\\.03372694411756104\ \(0\)\
\-\ invaded\\:\\ 0\\.033293144702109145\ \(0\)\
\-\ prostheses\\:\\ 0\\.033293144702109145\ \(0\)\
\-\ essentials\\:\\ 0\\.033293144702109145\ \(0\)\
\-\ fever\\:\\ 0\\.03328900636881658\ \(0\)\
\-\ 15\\:\\ 0\\.03317736955931014\ \(0\)\
\-\ three\\:\\ 0\\.03295834813968425\ \(0\)\
\-\ male\\:\\ 0\\.03279041129576906\ \(0\)\
\-\ drops\\:\\ 0\\.032786260852947766\ \(0\)\
\-\ artifacts\\:\\ 0\\.032786260852947766\ \(0\)\
\-\ iiib\\:\\ 0\\.032786260852947766\ \(0\)\
\-\ hope\\:\\ 0\\.032786260852947766\ \(0\)\
\-\ sj\\:\\ 0\\.032786260852947766\ \(0\)\
\-\ jb\\:\\ 0\\.032786260852947766\ \(0\)\
\-\ radiation\\:\\ 0\\.0325363480670379\ \(0\)\
\-\ infrequent\\:\\ 0\\.03233283779903642\ \(0\)\
\-\ urography\\:\\ 0\\.03233283779903642\ \(0\)\
\-\ sl\\:\\ 0\\.03233283779903642\ \(0\)\
\-\ hematemesis\\:\\ 0\\.031922666754163526\ \(0\)\
\-\ wb\\:\\ 0\\.031922666754163526\ \(0\)\
\-\ reproducible\\:\\ 0\\.03154820992815672\ \(0\)\
\-\ valuable\\:\\ 0\\.03154820992815672\ \(0\)\
\-\ cure\\:\\ 0\\.031203743040062362\ \(0\)\
\-\ diaphoresis\\:\\ 0\\.031203743040062362\ \(0\)\
\-\ precise\\:\\ 0\\.031203743040062362\ \(0\)\
\-\ concepts\\:\\ 0\\.031203743040062362\ \(0\)\
\-\ tenderness\\:\\ 0\\.030790461019296698\ \(0\)\
\-\ enhancing\\:\\ 0\\.03075690511968226\ \(0\)\
\-\ heterogeneity\\:\\ 0\\.03058790302508399\ \(0\)\
\-\ chapter\\:\\ 0\\.03058790302508399\ \(0\)\
\-\ fat\\:\\ 0\\.030541923712185504\ \(0\)\
\-\ attenuating\\:\\ 0\\.03031015900336568\ \(0\)\
\-\ paraneoplastic\\:\\ 0\\.03031015900336568\ \(0\)\
\-\ company\\:\\ 0\\.03031015900336568\ \(0\)\
\-\ year\\:\\ 0\\.030262012810761702\ \(0\)\
\-\ primary\\:\\ 0\\.03018991238398755\ \(0\)\
\-\ luq\\:\\ 0\\.03004925859874445\ \(0\)\
\-\ brant\\:\\ 0\\.03004925859874445\ \(0\)\
\-\ evaluation\\:\\ 0\\.029942654380048648\ \(0\)\
\-\ loss\\:\\ 0\\.02991224064752215\ \(0\)\
\-\ be\\:\\ 0\\.029875583357931005\ \(0\)\
\-\ multilocular\\:\\ 0\\.029803275154204296\ \(0\)\
\-\ photopenic\\:\\ 0\\.029803275154204296\ \(0\)\
\-\ technetium\\:\\ 0\\.029803275154204296\ \(0\)\
\-\ resnick\\:\\ 0\\.029803275154204296\ \(0\)\
\-\ when\\:\\ 0\\.029657973130477945\ \(0\)\
\-\ as\\:\\ 0\\.02958655394799495\ \(0\)\
\-\ granular\\:\\ 0\\.029570594776438433\ \(0\)\
\-\ indeterminate\\:\\ 0\\.029570594776438433\ \(0\)\
\-\ septa\\:\\ 0\\.029570594776438433\ \(0\)\
\-\ helms\\:\\ 0\\.029570594776438433\ \(0\)\
\-\ responses\\:\\ 0\\.029349852100292947\ \(0\)\
\-\ ranging\\:\\ 0\\.029349852100292947\ \(0\)\
\-\ ma\\:\\ 0\\.029349852100292947\ \(0\)\
\-\ from\\:\\ 0\\.02924940705997812\ \(0\)\
\-\ all\\:\\ 0\\.02922681066838945\ \(0\)\
\-\ subtypes\\:\\ 0\\.02893968105542006\ \(0\)\
\-\ hypercalcemia\\:\\ 0\\.028748381176041456\ \(0\)\
\-\ accuracy\\:\\ 0\\.028748381176041456\ \(0\)\
\-\ genitourinary\\:\\ 0\\.028748381176041456\ \(0\)\
\-\ vol\\:\\ 0\\.028748381176041456\ \(0\)\
\-\ fundamentals\\:\\ 0\\.028748381176041456\ \(0\)\
\-\ been\\:\\ 0\\.02860499316684208\ \(0\)\
\-\ resistant\\:\\ 0\\.028389545197220218\ \(0\)\
\-\ notes\\:\\ 0\\.028389545197220218\ \(0\)\
\-\ due\\:\\ 0\\.028222393408084873\ \(0\)\
\-\ epithelium\\:\\ 0\\.028220757341318896\ \(0\)\
\-\ mdp\\:\\ 0\\.028220757341318896\ \(0\)\
\-\ jr\\:\\ 0\\.028220757341318896\ \(0\)\
\-\ therapy\\:\\ 0\\.028209928413365705\ \(0\)\
\-\ cm\\:\\ 0\\.028197481444675557\ \(0\)\
\-\ oncocytoma\\:\\ 0\\.027901830817057702\ \(0\)\
\-\ yr\\:\\ 0\\.027901830817057702\ \(0\)\
\-\ common\\:\\ 0\\.027844133534632894\ \(0\)\
\-\ mild\\:\\ 0\\.027832204111587724\ \(0\)\
\-\ than\\:\\ 0\\.027832204111587724\ \(0\)\
\-\ groups\\:\\ 0\\.027750813965106442\ \(0\)\
\-\ patients\\:\\ 0\\.02762025442470155\ \(0\)\
\-\ pharyngeal\\:\\ 0\\.027604917326340524\ \(0\)\
\-\ dx\\:\\ 0\\.027604917326340524\ \(0\)\
\-\ malignancies\\:\\ 0\\.027604917326340524\ \(0\)\
\-\ contained\\:\\ 0\\.027604917326340524\ \(0\)\
\-\ utilized\\:\\ 0\\.02746380505568785\ \(0\)\
\-\ hispanic\\:\\ 0\\.02746380505568785\ \(0\)\
\-\ accompanying\\:\\ 0\\.027327173304622213\ \(0\)\
\-\ accounts\\:\\ 0\\.027327173304622213\ \(0\)\
\-\ radical\\:\\ 0\\.027194746281467636\ \(0\)\
\-\ dialysis\\:\\ 0\\.027194746281467636\ \(0\)\
\-\ von\\:\\ 0\\.027194746281467636\ \(0\)\
\-\ nodularity\\:\\ 0\\.027194746281467636\ \(0\)\
\-\ likelihood\\:\\ 0\\.027066272900000982\ \(0\)\
\-\ definition\\:\\ 0\\.027066272900000982\ \(0\)\
\-\ 91\\:\\ 0\\.027066272900000982\ \(0\)\
\-\ tx\\:\\ 0\\.02694152391398497\ \(0\)\
\-\ interface\\:\\ 0\\.026820289455460836\ \(0\)\
\-\ eomi\\:\\ 0\\.02670237691039737\ \(0\)\
\-\ familial\\:\\ 0\\.02670237691039737\ \(0\)\
\-\ wilkins\\:\\ 0\\.02670237691039737\ \(0\)\
\-\ consistent\\:\\ 0\\.026622008962054185\ \(0\)\
\-\ ingestion\\:\\ 0\\.026587609077694967\ \(0\)\
\-\ septations\\:\\ 0\\.026587609077694967\ \(0\)\
\-\ increased\\:\\ 0\\.026549810166696677\ \(0\)\
\-\ transitional\\:\\ 0\\.026475822567366473\ \(0\)\
\-\ excessive\\:\\ 0\\.026475822567366473\ \(0\)\
\-\ exophytic\\:\\ 0\\.02636686640154948\ \(0\)\
\-\ ext\\:\\ 0\\.02626060078828941\ \(0\)\
\-\ angiomyolipoma\\:\\ 0\\.02626060078828941\ \(0\)\
\-\ infected\\:\\ 0\\.02626060078828941\ \(0\)\
\-\ documented\\:\\ 0\\.02626060078828941\ \(0\)\
\-\ accomplished\\:\\ 0\\.02626060078828941\ \(0\)\
\-\ oncology\\:\\ 0\\.02626060078828941\ \(0\)\
\-\ basis\\:\\ 0\\.02626060078828941\ \(0\)\
\-\ destructive\\:\\ 0\\.026156896043105275\ \(0\)\
\-\ cold\\:\\ 0\\.026156896043105275\ \(0\)\
\-\ glands\\:\\ 0\\.026055631637467463\ \(0\)\
\-\ variety\\:\\ 0\\.025956695356676593\ \(0\)\
\-\ distortion\\:\\ 0\\.025956695356676593\ \(0\)\
\-\ williams\\:\\ 0\\.02576539547729799\ \(0\)\
\-\ role\\:\\ 0\\.02576539547729799\ \(0\)\
\-\ ultimately\\:\\ 0\\.02567284269138526\ \(0\)\
\-\ beyond\\:\\ 0\\.02558223853066979\ \(0\)\
\-\ most\\:\\ 0\\.025552034388420953\ \(0\)\
\-\ gallops\\:\\ 0\\.02549350263074972\ \(0\)\
\-\ scintigraphy\\:\\ 0\\.02549350263074972\ \(0\)\
\-\ myeloma\\:\\ 0\\.02549350263074972\ \(0\)\
\-\ mosby\\:\\ 0\\.02549350263074972\ \(0\)\
\-\ bs\\:\\ 0\\.02540655949847675\ \(0\)\
\-\ cr\\:\\ 0\\.02540655949847675\ \(0\)\
\-\ posterior\\:\\ 0\\.025388948043702172\ \(0\)\
\-\ o2\\:\\ 0\\.025321338126048556\ \(0\)\
\-\ organs\\:\\ 0\\.025321338126048556\ \(0\)\
\-\ 97\\:\\ 0\\.02523777164257543\ \(0\)\
\-\ mets\\:\\ 0\\.02523777164257543\ \(0\)\
\-\ hereditary\\:\\ 0\\.02523777164257543\ \(0\)\
\-\ organ\\:\\ 0\\.02523777164257543\ \(0\)\
\-\ syndromes\\:\\ 0\\.02523777164257543\ \(0\)\
\-\ robert\\:\\ 0\\.02523777164257543\ \(0\)\
\-\ po\\:\\ 0\\.025155796998837347\ \(0\)\
\-\ sweats\\:\\ 0\\.02507535468150841\ \(0\)\
\-\ 2008\\:\\ 0\\.02507535468150841\ \(0\)\
\-\ 82\\:\\ 0\\.024996388453603864\ \(0\)\
\-\ ttp\\:\\ 0\\.024996388453603864\ \(0\)\
\-\ hormone\\:\\ 0\\.024996388453603864\ \(0\)\
\-\ radiographics\\:\\ 0\\.024767828266362975\ \(0\)\
\-\ sat\\:\\ 0\\.02469426171128052\ \(0\)\
\-\ rubs\\:\\ 0\\.02469426171128052\ \(0\)\
\-\ 1999\\:\\ 0\\.02469426171128052\ \(0\)\
\-\ water\\:\\ 0\\.024550797137385554\ \(0\)\
\-\ 2000\\:\\ 0\\.024550797137385554\ \(0\)\
\-\ tuberous\\:\\ 0\\.024480819356944385\ \(0\)\
\-\ requiring\\:\\ 0\\.024480819356944385\ \(0\)\
\-\ ra\\:\\ 0\\.024277464739502697\ \(0\)\
\-\ modality\\:\\ 0\\.024277464739502697\ \(0\)\
\-\ gen\\:\\ 0\\.02421176058272417\ \(0\)\
\-\ genetic\\:\\ 0\\.02421176058272417\ \(0\)\
\-\ consider\\:\\ 0\\.024147044495901677\ \(0\)\
\-\ sharp\\:\\ 0\\.024147044495901677\ \(0\)\
\-\ multiple\\:\\ 0\\.024014851902537552\ \(0\)\
\-\ spleen\\:\\ 0\\.023897494089968253\ \(0\)\
\-\ surgical\\:\\ 0\\.023863181416702184\ \(0\)\
\-\ vena\\:\\ 0\\.023719391211653902\ \(0\)\
\-\ bun\\:\\ 0\\.023661624724524325\ \(0\)\
\-\ presents\\:\\ 0\\.02361862467008655\ \(0\)\
\-\ cava\\:\\ 0\\.023604623378951504\ \(0\)\
\-\ we\\:\\ 0\\.023604623378951504\ \(0\)\
\-\ murmurs\\:\\ 0\\.023548367170368616\ \(0\)\
\-\ 99m\\:\\ 0\\.023548367170368616\ \(0\)\
\-\ lesion\\:\\ 0\\.023538625910112625\ \(0\)\
\-\ rebound\\:\\ 0\\.023383880702806014\ \(0\)\
\-\ exposure\\:\\ 0\\.023330419907555987\ \(0\)\
\-\ minimally\\:\\ 0\\.023277615089545945\ \(0\)\
\-\ complicated\\:\\ 0\\.023277615089545945\ \(0\)\
\-\ 2001\\:\\ 0\\.02317391034436181\ \(0\)\
\-\ cta\\:\\ 0\\.023122980298184784\ \(0\)\
\-\ pancreas\\:\\ 0\\.023072645938723997\ \(0\)\
\-\ confirm\\:\\ 0\\.022973709657933127\ \(0\)\
\-\ adults\\:\\ 0\\.02292508158489182\ \(0\)\
\-\ rrr\\:\\ 0\\.022876996853644638\ \(0\)\
\-\ return\\:\\ 0\\.022876996853644638\ \(0\)\
\-\ papillary\\:\\ 0\\.022876996853644638\ \(0\)\
\-\ abd\\:\\ 0\\.022829443456267452\ \(0\)\
\-\ thrombus\\:\\ 0\\.022829443456267452\ \(0\)\
\-\ combination\\:\\ 0\\.022782409778554523\ \(0\)\
\-\ anatomic\\:\\ 0\\.022782409778554523\ \(0\)\
\-\ older\\:\\ 0\\.022782409778554523\ \(0\)\
\-\ smoking\\:\\ 0\\.02273588458299196\ \(0\)\
\-\ discomfort\\:\\ 0\\.022689856992641793\ \(0\)\
\-\ 85\\:\\ 0\\.02264431647587877\ \(0\)\
\-\ within\\:\\ 0\\.022612979155389304\ \(0\)\
\-\ hyperdense\\:\\ 0\\.022599252831926327\ \(0\)\
\-\ need\\:\\ 0\\.022599252831926327\ \(0\)\
\-\ 4th\\:\\ 0\\.022599252831926327\ \(0\)\
\-\ rr\\:\\ 0\\.022554656177142002\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.022554656177142002\ \(0\)\
\-\ unilateral\\:\\ 0\\.022466825808771747\ \(0\)\
\-\ arise\\:\\ 0\\.022466825808771747\ \(0\)\
\-\ extent\\:\\ 0\\.022466825808771747\ \(0\)\
\-\ chills\\:\\ 0\\.02233835242730509\ \(0\)\
\-\ hx\\:\\ 0\\.02233835242730509\ \(0\)\
\-\ components\\:\\ 0\\.022296366351111357\ \(0\)\
\-\ skeletal\\:\\ 0\\.022254785943831963\ \(0\)\
\-\ erythema\\:\\ 0\\.02221360344128908\ \(0\)\
\-\ expansile\\:\\ 0\\.02221360344128908\ \(0\)\
\-\ simple\\:\\ 0\\.02221360344128908\ \(0\)\
\-\ poorly\\:\\ 0\\.02217281130009388\ \(0\)\
\-\ options\\:\\ 0\\.02213240218935371\ \(0\)\
\-\ smaller\\:\\ 0\\.022092368982764943\ \(0\)\
\-\ contour\\:\\ 0\\.022092368982764943\ \(0\)\
\-\ night\\:\\ 0\\.022052704751070268\ \(0\)\
\-\ spread\\:\\ 0\\.022052704751070268\ \(0\)\
\-\ larger\\:\\ 0\\.02197445643770148\ \(0\)\
\-\ heent\\:\\ 0\\.02193585941957077\ \(0\)\
\-\ completely\\:\\ 0\\.02193585941957077\ \(0\)\
\-\ gross\\:\\ 0\\.02178484256761951\ \(0\)\
\-\ still\\:\\ 0\\.021747902094670587\ \(0\)\
\-\ vitals\\:\\ 0\\.021674959014949535\ \(0\)\
\-\ nature\\:\\ 0\\.021674959014949535\ \(0\)\
\-\ involve\\:\\ 0\\.021603231709987507\ \(0\)\
\-\ shift\\:\\ 0\\.021567811438642087\ \(0\)\
\-\ 75\\:\\ 0\\.021532680315593522\ \(0\)\
\-\ flank\\:\\ 0\\.021532680315593522\ \(0\)\
\-\ embolization\\:\\ 0\\.02139495532467071\ \(0\)\
\-\ tubular\\:\\ 0\\.021327711164771578\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.021294479040759238\ \(0\)\
\-\ unable\\:\\ 0\\.021261501571539984\ \(0\)\
\-\ afebrile\\:\\ 0\\.021196295192643523\ \(0\)\
\-\ iii\\:\\ 0\\.021196295192643523\ \(0\)\
\-\ subtle\\:\\ 0\\.021164058797158214\ \(0\)\
\-\ kidneys\\:\\ 0\\.02113206207969221\ \(0\)\
\-\ hr\\:\\ 0\\.02110030150251405\ \(0\)\
\-\ regions\\:\\ 0\\.021068773605645998\ \(0\)\
\-\ incidentally\\:\\ 0\\.020914508391224787\ \(0\)\
\-\ factors\\:\\ 0\\.02076558215805383\ \(0\)\
\-\ represent\\:\\ 0\\.020427876526141454\ \(0\)\
\-\ infarct\\:\\ 0\\.020427876526141454\ \(0\)\
\-\ resulting\\:\\ 0\\.020427876526141454\ \(0\)\
\-\ pe\\:\\ 0\\.02029462939080248\ \(0\)\
\-\ either\\:\\ 0\\.02029462939080248\ \(0\)\
\-\ arterial\\:\\ 0\\.020216617490138703\ \(0\)\
\-\ thrombosis\\:\\ 0\\.020015245613425305\ \(0\)\
\-\ cortex\\:\\ 0\\.01999072395918966\ \(0\)\
\-\ good\\:\\ 0\\.019966341238584626\ \(0\)\
\-\ bp\\:\\ 0\\.01991798636272955\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.019846457757523986\ \(0\)\
\-\ site\\:\\ 0\\.019799424079811057\ \(0\)\
\-\ best\\:\\ 0\\.019752898884248492\ \(0\)\
\-\ 35\\:\\ 0\\.019684040796456966\ \(0\)\
\-\ 21\\:\\ 0\\.019616267133182857\ \(0\)\
\-\ references\\:\\ 0\\.019571670478398535\ \(0\)\
\-\ nodules\\:\\ 0\\.01950563022581956\ \(0\)\
\-\ located\\:\\ 0\\.019419124023205787\ \(0\)\
\-\ occurs\\:\\ 0\\.019355366728561623\ \(0\)\
\-\ thyroid\\:\\ 0\\.01929254023064968\ \(0\)\
\-\ visualized\\:\\ 0\\.019169573617272364\ \(0\)\
\-\ results\\:\\ 0\\.0191293533369078\ \(0\)\
\-\ considered\\:\\ 0\\.0191293533369078\ \(0\)\
\-\ irregular\\:\\ 0\\.018952873720827303\ \(0\)\
\-\ partial\\:\\ 0\\.01891461979184052\ \(0\)\
\-\ cells\\:\\ 0\\.01891461979184052\ \(0\)\
\-\ nausea\\:\\ 0\\.018857869008910757\ \(0\)\
\-\ attenuation\\:\\ 0\\.01878334699657931\ \(0\)\
\-\ hypertension\\:\\ 0\\.01878334699657931\ \(0\)\
\-\ necrosis\\:\\ 0\\.01876491639592712\ \(0\)\
\-\ system\\:\\ 0\\.018728290313793586\ \(0\)\
\-\ colon\\:\\ 0\\.01869197331620607\ \(0\)\
\-\ reveals\\:\\ 0\\.018673929102456032\ \(0\)\
\-\ rate\\:\\ 0\\.0186024994348601\ \(0\)\
\-\ vomiting\\:\\ 0\\.018165045002886987\ \(0\)\
\-\ management\\:\\ 0\\.01813316679286773\ \(0\)\
\-\ throughout\\:\\ 0\\.018054489305858634\ \(0\)\
\-\ activity\\:\\ 0\\.018023416689464385\ \(0\)\
\-\ defect\\:\\ 0\\.01800796411029607\ \(0\)\
\-\ appears\\:\\ 0\\.017977224417638084\ \(0\)\
\-\ abnormality\\:\\ 0\\.017856415399149346\ \(0\)\
\-\ breast\\:\\ 0\\.01782673570444611\ \(0\)\
\-\ early\\:\\ 0\\.017695653327037392\ \(0\)\
\-\ pain\\:\\ 0\\.017569035812824967\ \(0\)\
\-\ peripheral\\:\\ 0\\.01755454105638472\ \(0\)\
\-\ risk\\:\\ 0\\.017540681016467042\ \(0\)\
\-\ venous\\:\\ 0\\.017526865471136077\ \(0\)\
\-\ calcification\\:\\ 0\\.017526865471136077\ \(0\)\
\-\ malignant\\:\\ 0\\.017499366727895\ \(0\)\
\-\ sclerosis\\:\\ 0\\.017485682968593187\ \(0\)\
\-\ 25\\:\\ 0\\.01739109589350308\ \(0\)\
\-\ extension\\:\\ 0\\.01737775157684334\ \(0\)\
\-\ wbc\\:\\ 0\\.017351186438943036\ \(0\)\
\-\ palpable\\:\\ 0\\.017246535965005593\ \(0\)\
\-\ involving\\:\\ 0\\.01719514981807305\ \(0\)\
\-\ status\\:\\ 0\\.01713176813230319\ \(0\)\
\-\ being\\:\\ 0\\.017106674541237064\ \(0\)\
\-\ labs\\:\\ 0\\.017007738260446194\ \(0\)\
\-\ liver\\:\\ 0\\.016935000663986084\ \(0\)\
\-\ areas\\:\\ 0\\.016667034851974825\ \(0\)\
\-\ size\\:\\ 0\\.01662208886980895\ \(0\)\
\-\ palpation\\:\\ 0\\.016555537976446356\ \(0\)\
\-\ swelling\\:\\ 0\\.01652264452707609\ \(0\)\
\-\ cases\\:\\ 0\\.016511735677953197\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.016436138324462325\ \(0\)\
\-\ bilaterally\\:\\ 0\\.01637238102981816\ \(0\)\
\-\ density\\:\\ 0\\.016278481915511962\ \(0\)\
\-\ radiograph\\:\\ 0\\.015989143260804473\ \(0\)\
\-\ superior\\:\\ 0\\.015960292614151862\ \(0\)\
\-\ differential\\:\\ 0\\.01595071855308497\ \(0\)\
\-\ adjacent\\:\\ 0\\.01591263389148497\ \(0\)\
\-\ area\\:\\ 0\\.01590316515570779\ \(0\)\
\-\ 20\\:\\ 0\\.01583746099892926\ \(0\)\
\-\ abscess\\:\\ 0\\.01576357869208213\ \(0\)\
\-\ resection\\:\\ 0\\.015736196593291445\ \(0\)\
\-\ medical\\:\\ 0\\.015601840041155156\ \(0\)\
\-\ clinical\\:\\ 0\\.015557970765511348\ \(0\)\
\-\ usually\\:\\ 0\\.015454473865521748\ \(0\)\
\-\ age\\:\\ 0\\.015412074126745426\ \(0\)\
\-\ diffuse\\:\\ 0\\.015395230509648349\ \(0\)\
\-\ only\\:\\ 0\\.015336791647128823\ \(0\)\
\-\ proximal\\:\\ 0\\.015336791647128823\ \(0\)\
\-\ lung\\:\\ 0\\.014933410304439416\ \(0\)\
\-\ infection\\:\\ 0\\.014828986565238973\ \(0\)\
\-\ focal\\:\\ 0\\.014684072581728975\ \(0\)\
\-\ likely\\:\\ 0\\.014669845994642057\ \(0\)\
\-\ lymphoma\\:\\ 0\\.014620420068713795\ \(0\)\
\-\ chronic\\:\\ 0\\.014571555357641253\ \(0\)\
\-\ however\\:\\ 0\\.014530108436882279\ \(0\)\
\-\ enhancement\\:\\ 0\\.014129948536214867\ \(0\)\
\-\ low\\:\\ 0\\.014086320688682246\ \(0\)\
\-\ these\\:\\ 0\\.013862788437872366\ \(0\)\
\-\ prior\\:\\ 0\\.013735180907297837\ \(0\)\
\-\ both\\:\\ 0\\.013689700550858502\ \(0\)\
\-\ upper\\:\\ 0\\.01311857893433684\ \(0\)\
\-\ soft\\:\\ 0\\.013069338824222098\ \(0\)\
\-\ chest\\:\\ 0\\.012958180045369928\ \(0\)\
\-\ without\\:\\ 0\\.012948648394353588\ \(0\)\
\-\ associated\\:\\ 0\\.012939137807776552\ \(0\)\
\-\ tissue\\:\\ 0\\.01287782608278461\ \(0\)\
\-\ other\\:\\ 0\\.012748664102075782\ \(0\)\
\-\ large\\:\\ 0\\.012300242784204326\ \(0\)\
\-\ findings\\:\\ 0\\.012115891713270682\ \(0\)\
\-\ contrast\\:\\ 0\\.011927833799623087\ \(0\)\
\-\ treatment\\:\\ 0\\.011693967710684377\ \(0\)\
\-\ has\\:\\ 0\\.011213245271417503\ \(0\)\
\-\ normal\\:\\ 0\\.010023171863317542\ \(0\)\
\-\ history\\:\\ 0\\.009379120230372061\ \(0\)\
\-\ at\\:\\ 0\\.009272449368401808\ \(0\)\
\-\ not\\:\\ 0\\.0\ \(0\)\
